ESTROGEN TREATMENT OF PATIENTS WITH CHRONIC BRAIN SYNDROME ASSOCIATED WITH CEREBRAL ATHEROSCLEROSIS
KENNETH LIFSHITZ M.D.1, and
NATHAN S. KLINE M.D.1
1 Research Facility, Rockland State Hospital, Orangeburg, N. Y.
For this severely impaired population of 37 patients suffering from chronic brain syndrome associated with cerebral atherosclerosis, treatment with 1.25 mg./day of conjugated equine estrogens over a period of about one year resulted in no measurable effect on psychological functioning or on mortality as compared to placebo treatment.
